Friday, August 4, 2017

New Treatment Approved for (AML) Leukemia

A new drug has been approved for high-risk types of Acute Myeloid Leukemia (AML)
Read doctor-produced health and medical information written for you to make informed decisions about your health concerns.
To view this email as a web page, Click Here
Aug 4, 2017 Facebook Twitter
FEATURED NEWS
New Treatment for (AML) Leukemia
New drug approved for high-risk types of Acute Myeloid Leukemia (AML). 
READ MORE
Can Breast Milk Feed a Love of Vegetables?
Yoga May Help Ease Depression
Protein at All 3 Meals May Help Preserve Seniors' Strength
Resistance Training May Slow MS, Study Says
See All News →
FEATURED SLIDESHOW
Causes of Erectile Dysfunction
Having erection problems? Learn about treatments such as drugs, pumps, and more.
VIEW SLIDESHOW
Crohn's Disease Causes, Symptoms, Diet
Warning Signs of AFib
Asthma Myths Debunked
Who's At Risk for Type 2 Diabetes?
See All Slideshows →
FEATURED QUIZ
How Well Do You Sleep?
Sleep hygiene is the sum of practices that promote regular, restful sleep.
TAKE THE QUIZ
What Is the Most Common Cancer?
The Leading Cause of Lung Cancer
Is Poor Oral Health Linked to Serious Diseases?
Learn How to Lower Your Cholesterol
See All Quizzes →
Health & Wellness Guide
BONUS
Health & Wellness Guide
Claim Your FREE PDF MedicineNet Health Report!
ADVERTISEMENT
HEALTH TOOLS
MEDICINENET NEWSLETTERS
Sign up for the NEW MedicineNet newsletters today! New specialty newsletters include Cancer, Heart, Pregnancy & Newborns, Children's Health & Parenting.
SIGN UP
FROM OUR WEBMD SPONSORS  arrow
You received this message because you signed up for the Daily Health News newsletter as brandee-garner-0662.7888@blogger.com.

Don't miss a single issue of this newsletter. Add MedicineNet.com to your email's safe sender list.

Need to add, change, or remove your subscriptions?
Manage your MedicineNet newsletter preferences here.

MedicineNet respects your privacy - view our Privacy Policy

MedicineNet
903 Calle Amanecer, Suite 300 San Clemente, CA 92673 USA
© MedicineNet, Inc. All rights reserved.

No comments:

Post a Comment